Evidence map›Paper›PMID 39310220›Full record

ArticlePhysics and imaging in radiation oncology2024

In vivo dosimetry with an inorganic scintillation detector during multi-channel vaginal cylinder pulsed dose-rate brachytherapy: Dosimetry for pulsed dose-rate brachytherapy.

Peter D Georgi, Søren K Nielsen, Anders T Hansen, Harald Spejlborg, Susanne Rylander, Jacob Lindegaard, Simon Buus, Christian Wulff, Primoz Petric, Kari Tanderup and 1 more

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Breakthroughs in modern brachytherapy are transforming cancer care.Physics and imaging in radiation oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Peter D GeorgiDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Søren K NielsenDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Anders T HansenDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Harald SpejlborgDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Susanne RylanderDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Jacob LindegaardDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Simon BuusDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Christian WulffDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Primoz PetricDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Kari TanderupDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Jacob G JohansenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: In vivo dosimetry is not standard in brachytherapy and some errors go undetected. The aim of this study was to evaluate the accuracy of multi-channel vaginal cylinder pulsed dose-rate brachytherapy using in vivo dosimetry. Materials and methods: In vivo dosimetry data was collected during the years 2019-2022 for 22 patients (32 fractions) receiving multi-channel cylinder pulsed dose-rate brachytherapy. An inorganic scintillation detector was inserted in a cylinder channel. Each fraction was analysed as independent data sets. In vivo dosimetry-based source-tracking was used to determine the relative source-to-detector position. Measured dose was compared to planned and re-calculated source-tracking based doses. Assuming no change in organ and applicator geometry throughout treatment, the planned and source-tracking based dose distributions were compared in select volumes via γ-index analysis and dose-volume-histograms. Results: The mean ± SD planned vs. measured dose deviations in the first pulse were 0.8 Conclusions: In vivo dosimetry verified accurate and stable dose delivery in multi-channel vaginal cylinder based pulsed dose-rate brachytherapy.

Indexed as

Inorganic scintillatorPulsed dose-rate brachytherapyTime-resolved in vivo dosimetry

Identifiers

PMID39310220
PMCPMC11413746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.